Legend Biotech Corporation - American Depositary Shares — Cash Flow (NASDAQ:LEGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 223 M198.47 M201.28 M393.28 M144.03 M — Cash from investing activities 24.17 M194.98 M77.09 M92.79 M850.54 M — Cash from financing activities 618.88 M626.66 M377.98 M791.49 M5.7 M — Free cash flow 223 M198.47 M201.28 M393.28 M144.03 M —

Noticias

These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies.

What Gilead Is Getting Through The Acquisition Of Arcellx

American Express, Oracle among market cap stock movers on Monday

Raymond James reitera calificación de acciones de Legend Biotech por brecha de valoración

Raymond James reitera calificación de Legend Biotech por brecha de valuación

Raymond James reiterates Legend Biotech stock rating on valuation gap

Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J

Germany stocks lower at close of trade; DAX down 1.03%

Las bolsas de valores de Alemania cerraron con caídas; el DAX perdió un 1.03%

Germany stocks higher at close of trade; DAX up 1.16%

Las bolsas de valores de Alemania cerraron con subidas; el DAX ganó un 1.16%

Rothschild Redburn rebaja calificación de Legend Biotech por preocupaciones de competencia